A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Abcuro, Inc.
Start Date
June 27, 2023
End Date
December 31, 2027
Administered By
Neurology, Neuromuscular Disease
Awarded By
Abcuro, Inc.
Start Date
June 27, 2023
End Date
December 31, 2027